-
1Academic Journal
Συγγραφείς: V. A. PARFYONOV, S. V. VERBITSKAYA, В. А. ПАРФЕНОВ, С. В. ВЕРБИЦКАЯ
Πηγή: Meditsinskiy sovet = Medical Council; № 11 (2016); 18-24 ; Медицинский Совет; № 11 (2016); 18-24 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2016-11
Θεματικοί όροι: Диваза, non-pharmacological methods for stroke prevention, antithrombotic agents, antihypertensives, post stroke cognitive impairment, Divaza, нелекарственные средства профилактики инсульта, антитромботические средства, антигипертензивные средства, постинсультные когнитивные нарушения
Περιγραφή αρχείου: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/1534/1490; Sacco RL, Adams R, Albers G et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke, 2006, 37: 577-617.; European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis, 2008, 25: 457-507.; Furie KL, Kasner SE, Adams RJ et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2011, 42: 227-276.; Cerebrovascular disease, cognitive impairment and dementia. Second edition of Cerebrovascular disease and dementia. Edited by O’Brien J, Ames D, Gustafson L et al. Martin Dunitz. 2004.; Gorelick PB, Scuteri A, Black SE et al. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2011, 42: 2672-2713.; Eskes GA, Lanctôt KL, Herrmann N et al. Canadi an Stroke Best Practice Recommendations: Mood, Cognition and Fatigue Following Stroke practice guidelines, update 2015. Int J Stroke, 2015 Jun 29. doi:10.1111/ijs.12557; Larrieu S, Letenneur L, Helmer C et al. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J Nutr Health Aging, 2004, 8: 150-154.; Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychological Science, 2003, 14: 125-130.; Scarmeas N, Stern Y, Mayeux R et al. Mediterranean diet and mild cognitive impairment. Arch Neurol, 2009, 66: 216-225.; Gates N, Valenzuela M. Cognitive exercise and its role in cognitive function in older adults. Curr Psychiatry Rep, 2010, 12: 20-27.; Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002, 324: 71-86.; Kernan WN, Ovbiagele B, Black HR. et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2014, 45: 2160-2236.; Connolly S, Ezekowitz MD, Ysuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med, 2009, 361: 1139-1151.; Granger CB, Alexander JH, McMurray JJV et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med, 2011, 365: 981-992.; Patel МR, Mahaffey KW, Garg J et al. Rivaroxaban versus Warfarin in Nonvalvular trial Fibrillation. N Engl J Med, 2011, 365: 883-891.; Rashid P, Leonardi-Bee J, Bath PP. Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events. Stroke, 2003, 34: 2741-2748.; Patterson C, Feightner JW, Garcia A et al. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. Canadian Medical Association Journal, 2008, 178: 548-556.; Rothwell PM, Howard SC, Spence JD for the Carotide Endarterectomy Trialist`s Collaboration. Relationship between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease. Stroke, 2003, 34: 2583-2592.; Вербицкая С.В., Парфенов В.А. Вторичная профилактика инсульта в амбулаторных условиях. Неврологический журнал, 2011, 1: 17-21.; Schaapsmeerders P, Maaijwee NAM, van Dijk EJ et al. Long-Term Cognitive Impairment After First-Ever Ischemic Stroke in Young Adults. Stroke, 2013, 44: 1621-1628.; Sachdev PS, Lipnicki DM, Crawford JD et al. Progression of cognitive impairment in stroke/ TIA patients over 3 years. J Neurol Neurosurg Psychiatry, 2014, 85: 1324-1330.; Парфенов В.А., Хасанова Д.Р. Ишемический инсульт. М.: МИА, 2012. 288 с.; Эпштейн О.И. Сверхмалые дозы (история одного исследования). М.: Издательство РАМН, 2008. 336 с.; Эпштейн О.И., Дыгай А.М., Шерстобоев Е.Ю. и др. Экспериментальное исследование фармакологических эффектов сверхмалых доз антител к эндогенным регуляторам функций. Бюл. экспер. биол. и медицины, 2008, Приложение 2: 82-88.; Камчатнов П.Р., Воробьева О.В., Рачин А.П. Коррекция эмоциональных и когнитивных нарушений у пациентов с хронической ишемией головного мозга. Журнал неврологии и психиатрии, 2014, 4: 52-57.
-
2Academic Journal
Συγγραφείς: Парфенов, Владимир, Вербицкая, Светлана
Θεματικοί όροι: ВТОРИЧНАЯ ПРОФИЛАКТИКА ИШЕМИЧЕСКОГО ИНСУЛЬТА, НЕЛЕКАРСТВЕННЫЕ СРЕДСТВА, ПРОФИЛАКТИКА ИНСУЛЬТА, АНТИТРОМБОТИЧЕСКИЕ СРЕДСТВА, АНТИГИПЕРТЕНЗИВНЫЕ СРЕДСТВА, СТАТИНЫ, КАРОТИДНАЯ ЭНДАРТЕРЭКТОМИЯ
Περιγραφή αρχείου: text/html
-
3Academic Journal
Πηγή: Неврологический журнал.
Θεματικοί όροι: ВТОРИЧНАЯ ПРОФИЛАКТИКА ИШЕМИЧЕСКОГО ИНСУЛЬТА, НЕЛЕКАРСТВЕННЫЕ СРЕДСТВА, ПРОФИЛАКТИКА ИНСУЛЬТА, АНТИТРОМБОТИЧЕСКИЕ СРЕДСТВА, АНТИГИПЕРТЕНЗИВНЫЕ СРЕДСТВА, СТАТИНЫ, КАРОТИДНАЯ ЭНДАРТЕРЭКТОМИЯ, 3. Good health
Περιγραφή αρχείου: text/html
